Astrana Health, Inc. (ASTH) — Fair Value Analysis

Base-case fair value (P50): $48.77 · Current price: $40.81 · Verdict: Undervalued

The Verdict on ASTH

Based on advanced Monte Carlo simulations, ASTRANA HEALTH INC (ASTH) appears to be Fairly Valued at its current market price of $40.81. Our analysis indicates a median fair value (P50) of $48.77, suggesting a potential +19.5% upside from current levels. While this potential upside is notable, the Monte Carlo model's comprehensive distribution suggests the stock is currently trading within a reasonable range of its intrinsic value. This "Fairly Valued" assessment reflects a balance between the calculated upside and the inherent volatility in forward projections for ASTH.

How ASTH stacks up against peers

ASTRANA HEALTH INC's operational and financial health is currently rated as average within its relevant peer group. This quality tier is a crucial input for our Monte Carlo simulations, influencing the range and probability distribution of future cash flows and, consequently, the fair value estimate of $48.77. Companies with an average quality rating often present a balanced risk-reward profile, where the upside potential from $40.81 to $48.77 is considered achievable, but not without typical sector-specific challenges. The average quality tier suggests ASTH is neither a clear standout nor a laggard when compared to its contemporaries, aligning with the "Fairly Valued" verdict and the implied +19.5%.

What this means for investors

Investors evaluating ASTH at $40.81 should consider the +19.5% potential towards the median fair value of $48.77 as a key data point, consistent with our "Fairly Valued" verdict. Given the average quality tier, the Monte Carlo simulations provide a robust framework for understanding the likely range of outcomes for ASTRANA HEALTH INC. While the current price sits below the P50 estimate, indicating some room for growth, the "Fairly Valued" status suggests a measured expectation rather than a deep undervaluation. For a deeper dive into the specific bear and bull case scenarios and their probabilities, a free FairCurve account provides the complete distribution. Sign up for FairCurve to see the full bear/bull distribution and track ASTH's fair value as new fundamentals are released.